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Abstract 
 
RxNorm was utilized as the basis for direct-capture of medication history data in a live EHR system 
deployed in a large, multi-state outpatient behavioral healthcare provider in the United States serving 
over 75,000 distinct patients each year across 130 clinical locations.  This tool incorporated auto-
complete search functionality for medications and proper dosage identification assistance.  The 
overarching goal was to understand if and how standardized terminologies like RxNorm can be used to 
support practical computing applications in live EHR systems.  We describe the stages of 
implementation, approaches used to adapt RxNorm’s data structure for the intended EHR application, 
and the challenges faced.  We evaluate the implementation using a four-factor framework addressing 
flexibility, speed, data integrity, and medication coverage.  RxNorm proved to be functional for the 
intended application, given appropriate adaptations to address high-speed input/output (I/O) 
requirements of a live EHR and the flexibility required for data entry in multiple potential clinical 
scenarios.   Future research around search optimization for medication entry, user profiling, and linking 
RxNorm to drug classification schemes holds great potential for improving the user experience and 
utility of medication data in EHRs. 
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1. Introduction 
 RxNorm is a standardized, controlled terminology for medications in the United States.  It 
includes multiple components – medication name (both generic and brand), dosage, route of 
administration, ingredients, and fully-specified “common dose forms” (i.e., what a physician might enter 
as part of a prescription to a pharmacy) [1].  These multiple components are linked together through a 
relational file structure, easily portable into database format [2].  RxNorm was originally developed as 
part of the Unified Medical Language System (UMLS) effort to integrate and map diverse and competing 
controlled medical terminologies in order to facilitate interoperability and data exchange across 
healthcare providers [3].  Early work that led to the development of RxNorm in UMLS was spurred by 
efforts of the HL7 Vocabulary Technical Committee in the late 1990’s [1]. 
 A major goal in developing RxNorm was to provide a consistent, standardized way to identify 
the essential components of prescriptions for purposes of facilitating electronic capture of such data in 
electronic health records (EHRs) to support the exchange of patient information across providers (i.e., 
interoperability), development of clinical decision support systems (CDSS), quality improvement efforts, 
and other research endeavors.  Early efforts to utilize RxNorm have primarily focused on: 1) navigating 
between names/codes across differing vocabularies and home-grown legacy systems, 2) exchanging 
data across providers, and 3) developing medication-related CDSS [1].  Many of these efforts have taken 
the approach of mapping existent EHR data into RxNorm format post-hoc [2,4], although there are an 
increasing number of efforts to develop “direct capture” methods where prescription data are captured 
in RxNorm format at the point of data entry [1,2,5].  However, there is limited evidence about the use 
and implementation of RxNorm in actual clinical practice outside of such research settings [2]. 
 RxNorm has taken on increased importance with development of Meaningful Use standards in 
the United States, which specified the use of RxNorm for medication data in early drafts of the 
standards [6].  Although the explicit requirement was removed in the final draft for Stage 1 Meaningful 
Use, the standards still encourage RxNorm use, and there is a strong belief that RxNorm or an equivalent 
tool will be required at Stage 2 or 3 of Meaningful Use when those standards are released in order to 
achieve the overarching goal of interoperable health records. 
 As such, an increasing need exists to look for alternate methods (averse to, e.g., post-hoc 
mapping) for capturing and transforming EHR medication data into RxNorm format.  This includes new 
e-prescriptions as they are ordered (i.e., e-prescribing), as well as medications previously prescribed 
(i.e., medication history) [7].  Medication history in a clinical (not pharmacy) context includes such 
history (at least within some reasonable time frame, e.g., the past two years) for a patient prior to the 
current provider’s treatment episode, often provided by the patient themselves.  Collection of such 
information is specified as part of Meaningful Use, and such data can be critically important for 
identification of proper treatment, adjusting baseline outcomes, and reducing medical errors due to 
drug interactions [8].  For example, a patient suffering from Major Depression who was on citalopram 20 
mg until 3 months prior to the start of treatment with a new provider may not represent a true baseline 
due to residual effects of the previous treatment [9,10].  In order to evaluate such a patient, as well as 
to properly account for potential outcome improvement (or lack thereof), it is thus essential to know the 
patient’s medication history.  This sort of baseline adjustment would also be a necessity in any pay-for-
performance paradigm.   
In the future, patient medication history information will theoretically be available electronically 
via data exchange across provider EHRs.  However, such electronic exchange is not imminent, and 
current methods for collecting medication history present broad challenges [1].  For the time being, 
systems are needed that are capable of capturing such history in a standardized format in the current 
provider’s EHR.  Such systems would also establish the necessary data infrastructure for future 
electronic exchange of standardized medication history data across providers, once such capabilities 
become widely available.  Additionally, since medication history is typically captured via patient self-
report, techniques for applying RxNorm for capturing medication history in live clinical settings and EHRs 
are directly applicable to capturing similar information in research study settings [2]. 
 There are two possible methods for capturing medication history, as mentioned above: 1) 
Mapping data from legacy systems into RxNorm post-hoc, or 2) Direct capture of data in RxNorm-
compatible format at the point of data entry.  Challenges with the former scenario in real-world EHR 
systems include the fact that only a certain percentage of medications map correctly, even with 
sophisticated algorithms [11] or intensive, post-hoc manual matching by researchers, and that many 
successful mapping efforts have been limited to well-defined subsets containing only fully-specified 
prescriptions incorporating National Drug Codes (NDCs) [12]. Even the most sophisticated algorithms 
cannot overcome  all the limitations of poorly collected medication history at the point-of-care, such as 
open-ended free text fields, non-standard abbreviations, or invalid combinations due to uncontrolled 
data capture (e.g., recording  a medication in a non-existent dose unit or dose form).   Limiting 
medication data to particular subsets or engaging in post-hoc manual mapping efforts is not feasible for 
real-world systems.  Direct capture avoids some of these issues; however, there are challenges with this 
approach as well.   For example, a medication missing in a search list can prevent data entry from 
occurring (i.e., “medication coverage”).  The direct capture approach also necessitates transforming the 
complex relational structure of the original RxNorm tables into a bare-bones structure to populate 
fields/search boxes in a web screen that can support the high-speed input/output (I/O) required for such 
applications, maintain high data quality, and allow for flexibility in data capture [2,5].   Additionally, any 
direct capture system must be capable of handling multiple potential clinical scenarios, such as allowing 
for partial data capture when the patient does not recall specific information or lacks the faculties to 
report complete information (e.g., an individual experiencing psychotic schizophrenia).  Search 
functionality used in direct capture approaches can also open up further issues around search 
optimization and information retrieval filtering, commonly applied to web search (see Discussion). 
 Here, we describe an approach to direct capture utilizing RxNorm in a live EHR system deployed 
in a large, multi-state outpatient behavioral healthcare provider in the United States (Centerstone), 
serving over 75,000 distinct patients each year across 130 clinical locations.  The overarching goal is to 
understand if and how standardized terminologies like RxNorm can be used to support such practical 
computing applications in live EHR systems. 
 
2. Methods 
 RxNorm data was obtained from the NIH/NLM’s UMLS website as part of the comprehensive 
UMLS download (http://www.nlm.nih.gov/research/umls/) and loaded into Centerstone’s existent data 
warehouse infrastructure, running on Postgres 9.0, via the open-source Extraction Transformation Load 
(ETL) tool Pentaho Kettle (version 3.2, http://kettle.pentaho.com/).  The original version used in 
development was 2010AB, although 2011AA is currently being used.   Extracts of RxNorm data were 
made from this UMLS dataset and loaded into Centerstone’s EHR production database, running on 
Oracle 10.2.  This EHR is a heavily customized version of the Qualifacts CareLogic system 
(http://www.qualifacts.com/).   The subsequent activities were performed during a complete re-design 
of the intake module in the EHR.  Although initial development was performed using RxNorm extracts 
from the UMLS dataset, equivalent (and more frequently updated – weekly rather bi-annually) RxNorm-
specific download files can be obtained from the UMLS website 
(http://www.nlm.nih.gov/research/umls/rxnorm/docs/rxnormfiles.html).  For live clinical use, the direct 
monthly/weekly RxNorm files would be preferred.  For all practical purposes, the extraction of data from 
either source is equivalent, except for table names and some slight variation in a couple of column 
names (CUI >> RXCUI and AUI>>RXAUI), and subsequent technical details below can be substituted for 
one source or the other (code for both is available in the appendix).   It should be noted that some of the 
data described below (e.g., dose frequency) was derived from other terminologies such as SNOMED CT 
where RxNorm was lacking.   
 The nature of the legacy medication history data in the system, as well as new data captured 
directly from patients, is problematic in terms of quality and consistency.  Patients often cannot 
remember the exact dosage taken, let alone other aspects of prescriptions that RxNorm dictates (such 
as dose units, dose form, and route of administration).  Additionally, other requirements (e.g., state, 
payer, accreditation bodies) require only medication name and dosage (amount and units).  Meaningful 
Use itself does not currently specify the medication components to be captured in medication history.  
Given these conditions,  for purposes of this study and the re-design process, we focused only on 
capturing Clinical Drug data (as defined by Richesson et al. [2]) – medication name and dosage (amount 
and units), segmenting each RxNorm component into independent fields and leaving dose form/route 
(e.g., tablet, capsule, topical cream) for future work.  Henceforth, we use dosage to refer to the 
combination of dose amount and dose units and common form to refer to the RxNorm specified 
components of generic ingredient – dose amount – dose units – branded name[if applicable]  for each 
commonly prescribed dosage for each medication.  Dose frequency (e.g., q.d., b.i.d.) was also captured 
independently of this RxNorm construct using SNOMED CT codes derived from UMLS.  We extracted 
SNOMED terms for the most commonly used ranges (as agreed upon separately by a Health Information 
Exchange Centerstone is part of comprising six of the largest outpatient behavioral healthcare providers 
in the United States).  This included terms such as qd – “once a day”, qam – “Once a day, in the 
morning”, qpm – “Once a day, in the evening”, “qhs - Once a day, before bed”, bid – “Twice Daily”, tid – 
“Three times daily”, “qid - Four times daily”, qod – “Every other day,” prn – “As Required”, and mdu – 
“As Directed”.   This list could be amended as needed to cover additional terms, including terms not 
covered by any terminology in UMLS.  
 
2.1 Direct Capture – Technical Implementation 
 The aim of direct capture, at the suggestion of active clinicians, was to emulate the functionality 
of the Medicare Part D website formulary search 
(http://plancompare.medicare.gov/pfdn/FormularyFinder/).  This website allows active searching for 
medication names, an auto-complete suggestion feature as the user types (familiar to many readers 
from Google search), brand/generic identification, and modal popup functionality with common dosage 
information specific to each selected medication (to facilitate accurate dosing information capture).    
The structure of RxNorm in its UMLS download structure is not directly amenable to use as the basis for 
such a system [5], in particular with consideration for I/O performance in a large, high-volume EHR.  For 
such an application to function effectively without noticeable lag-time, it is imperative to cache as much 
data on the server-side web application.  With the addition of the dynamically defined lists and search 
boxes, this means that minimizing the number and time of round-trips to the database over the network 
(the “I/O” in this case) is of principal concern.  This entails a strategy of normalizing the data into the 
smallest possible subsets that could be searched quickly via efficient indexes and used to construct the 
minimal web caches in order to support front-end functionality with minimal lag time, even in the face 
of potential hundreds or thousands of concurrent users.  In other words, we operationalized the basic 
premise behind modern relational databases [13].  The need thus existed for several different types of 
information:  
1) A concise list of medication names for populating the auto-complete search feature  
2) Commonly prescribed dosages displayed as the common forms for each medication (for 
populating the modal popup and auto-populating the entire screen, see figure 3 below and 
the Medicare D website above as an example)  
3) A concise list of all known dose units (e.g., MG, MG/ML, MEQ/ML) to correctly delimit the 
selectable dose units for each medication (i.e. this prevents clinicians from selecting non-
existent dose units for a particular medication)   
 
Of particular interest was separating dose amount and dose units into separate, unlinked fields; 
such a design allows clinicians to manually edit either field independently to enter an atypical dosage 
(e.g.  off-label use).  This separation is useful for evaluating specific changes in dosage for research or 
analytical purposes, as well as algorithm development for CDSS purposes.  Otherwise we are comparing 
string fields of dosage information for variation or to identify medication changes, which can be 
imprecise and difficult to parse across patients.  Data integrity can be maintained by delimiting the 
possible dose units that a clinician can enter for a given medication to those units known to be 
applicable (derived from RxNorm itself).  
 This approach for implementation and visual display of RxNorm information is similar yet 
different from what has been proposed elsewhere [2,5] particularly in regards to utilizing both re-
structured production tables of RxNorm data and optimized search functionality.  In this case, we were 
essentially re-structuring RxNorm data into specialized production tables to allow for improvements in 
speed and flexibility.   This is in essence the same as the general design differences necessitated in a 
transactional (Online Transaction Processing - OLTP) production system relative to an Online Analytical 
Processing (OLAP) system, such as a data warehouse. 
A mockup of the screen was designed as a starting point in Balsamiq (http://balsamiq.com/, 
Figure 1).   
Figure 1: Intake Medication History Mockup 
 
  
Data was extracted from the original RxNorm UMLS tables to populate tables underlying this 
screen and the embedded search features.  Common dosage prescriptions (e.g., "aripiprazole 10 MG 
[Abilify]") were pulled as the full name from the UMLS concept table (MRCONSO).  The concise 
medication name (e.g., “Abilify”) was pulled from the UMLS relationship table (MRREL) using 
rela='has_ingredient'.  Dose amount and units was pulled from the UMLS attribute table (MRSAT) using 
atn='RXN_STRENGTH'.  CUI and AUI unique identifiers were pulled for each medication.  The AUI 
identifier of the generic form of brand-name medications was also pulled from the UMLS relationship 
(MRREL) table using rela='tradename_of', except in the case of multiple generics or multiple ingredients 
(as in some branded OTC drugs).  Finally, a flag was set using the “tty” field from the UMLS concept table 
(MRCONSO) to distinguish between generic  and brand-name medications.  “Brand of” medication 
records were also suppressed, as suggested in previous literature [5].  The full multi-stage SQL code and 
DDL code for extracting this information is available in the appendix, for both the UMLS and 
monthly/weekly RxNorm files.  The SQL code was executed via the open-source ETL tool Kettle (see 
above).  There was some limited suppression of obvious exceptions, such as non-human medications 
(e.g., pet shampoos), which can be seen in the appendix code. 
 The final table structure was comprised of three tables (Med_List, Med_List_Common, and 
Med_List_Dose), populated by embedding the SQL code in the appendix into an ETL process (via Kettle).    
The search functionality utilizes the AutoComplete extender from the Ajax Control Toolkit for ASP.NET, 
set up to suggest possible complete medication names once the user has entered at least two letters, 
displaying only the top twelve results.  String matching is unanchored and can match any segment of the 
medication name, including beginning, middle, or end.  The end user can continue typing to refine the 
search, with the results automatically filtered/updated with each keystroke.  Medication Name 
information was cached on the server side with a 2 hour expiration policy (requiring cached data to be 
deleted or updated every two hours).  A 70 millisecond delay was set on the search box text for updating 
results, which allows the results to filter seamlessly as the user types. 
  
2.2 Implementation Evaluation 
 In order to evaluate the success of using RxNorm as the basis for a direct-capture medication 
history tool, as well as to understand if and how it could be used as the underlying data structure for 
such practical computing applications, we propose a four-factor framework of analysis.  These factors 
are: 
1) Flexibility – RxNorm data and the resulting applications should allow for the variety of 
scenarios that may play out in real-world data capture situations. 
2) Speed – The application response time should be fast enough to generally be imperceptible 
to the end user.   
3) Data Integrity – RxNorm data should provide high-quality, reliable data with consistent 
mappings (from the EHR data) back to the original source (RxNorm/UMLS), even in the face 
of flexibility (#1) needs. 
4) Coverage –RxNorm should cover all commonly prescribed medications. 
 
All of these factors are discussed in more detail in the Results.  However, it should be noted that 
speed – measured as response time – was estimated by running the application using different 
medications with different medication component values (number of dose forms, number of dose units, 
etc.).  Higher values presented a larger search space and thus longer run-times.  
The above framework would be extensible to any standardized terminology implemented as 
part of a practical computing application in some provider EHR system.  Generally, the framework would 
apply across most settings, though medications of interest may differ (e.g., in this study, in a behavioral 
healthcare setting, we are primarily interested in coverage of psychotropic medications and medications 
for common chronic health disorders, such as diabetes and hypertension) [2].  It is important to note 
that the four factors may be ascertained independently (e.g., demonstrating data integrity only), though 
such an approach is not typical in many real-world implementations.  In such settings, the factors may 
compete (e.g., flexibility vs. data integrity), and the principle goal is to evaluate the factors as a whole, 
not individually. 
The above factors are very similar to frameworks described elsewhere [1,5, 14] although the 
terminology and the definitions vary slightly.  For instance, the framework concepts depicted in Fung et 
al. [5] map roughly as: unambiguity to data integrity, naturalness to flexibility, efficiency to speed, and 
coverage to coverage.  Thus, there seems to be some emerging consensus on the approach to 
evaluating the implementation of standardized terminologies such as RxNorm. 
  
3. Results  
The final result was searchable information for 18708 known medications and over 42,000 
common dose forms thereof.  This information allowed clinicians (and patients) to search for previously 
prescribed medications and assist with capturing accurate dosing information (as seen in figures 2 and 
3). The response time on the medication auto-complete search feature was measurable in milliseconds 
and generally imperceptible to the end user during human factors testing (described in forthcoming 
publications).  
 
 
 
 
 
 
Figure 2: Medication Name Search 
 
 
Figure 3: Medication Dosage Selector – Modal Popup 
  
 
Figures 2 and 3 are driven off of 3 queries (in these examples searching for the brand name drug 
Prozac), with information partially cached on the server-side during end user interaction to enable 
efficient search/auto-complete functionality (see Methods).  These queries are as follows: 
 
To populate the search box: 
Select med_list_id, med_name 
from cen.med_list m 
order by upper(med_name) 
; 
 
With “med_name” shown  in the search box (See Figure 2).  Selecting a particular medication 
opens a modal popup (Figure 3), which is populated by the following: 
 
To populate the modal popup: 
Select c.med_list_id, med_name, common_form, dose_amt, dose_units 
from cen.med_list_common c, cen.med_list m 
where c.med_list_id=m.med_list_id 
and c.med_list_id=? 
order by upper(med_name), dose_units, dose_amt 
; 
 
Where the question mark above is replaced by the actual med_list_id of the medication selected 
in the search box.   The “common_form” field is shown in the popup.  Once the user makes a selection 
(including a dummy option for “unknown”), med_name, dose_amt, and dose_units are loaded into the 
appropriate fields.  The user can still manually adjust the dosing information at that point, which 
necessitates delimiting the possible dose_units for the selected medication for that dropdown field. 
 
To limit the options in the dose units field: 
Select med_list_id, dose_units 
from cen.med_list_dose 
where med_list_id=? 
; 
  
 The results of the modal popup query can be seen in Table 1 (for Abilify) and Table 2 (for Zoloft).  
Note the query returned both the “common_form” field for selection display as well as fields for 
populating individual fields (e.g., dose_amt and dose_units) and returning a unique key for populating 
the backend tables after a selection was made. 
 
Table 1: Modal Popup – Behind-the-Scenes Query Results - Abilify 
MED_LIST_ID MED_NAME COMMON_FORM DOSE_AMT DOSE_UNITS 
18949 Abilify aripiprazole 2 MG [Abilify] 2 MG 
18949 Abilify aripiprazole 5 MG [Abilify] 5 MG 
18949 Abilify aripiprazole 10 MG [Abilify] 10 MG 
18949 Abilify aripiprazole 15 MG [Abilify] 15 MG 
18949 Abilify aripiprazole 20 MG [Abilify] 20 MG 
18949 Abilify aripiprazole 30 MG [Abilify] 30 MG 
18949 Abilify aripiprazole 1 MG/ML [Abilify] 1 MG/ML 
18949 Abilify aripiprazole 7.5 MG/ML [Abilify] 7.5 MG/ML 
 
Table 2: Modal Popup – Behind-the-Scenes Query Results – Zoloft 
MED_LIST_ID MED_NAME COMMON_FORM DOSE_AMT DOSE_UNITS 
37694 Zoloft Sertraline 25 MG [Zoloft] 25 MG 
37694 Zoloft Sertraline 50 MG [Zoloft] 50 MG 
37694 Zoloft Sertraline 100 MG [Zoloft] 100 MG 
37694 Zoloft Sertraline 20 MG/ML [Zoloft] 20 MG/ML 
 
 Selection of a common dosage, as seen in Figure 3, would then populate the remaining 
appropriate fields of the overall screen (medication, dosage).  The end user can still manually edit any 
field, and an option always exists in the modal popup if the exact dosage is unknown.  Additionally, an 
“Other Units” dummy option is provided for all medications for situations when the standard dose units 
are not inclusive of some atypical dosing regimen, which can occur with some less commonly used 
medications.  Generally, such an approach allows for flexibility, at least in terms of dosing.  The trade-off 
is that the quality of the data can be compromised when coding back into standard RxNorm common 
dose forms due to missing or non-standard data.  However,  the capability exists to reconstruct RxNorm 
format from the component parts via SQL query, and at a minimum the medication name can still be 
mapped using the CUI/AUI identifiers.  Importantly, these identifiers are stored and associated with 
specific, controlled terms at different levels of the hierarchy, so it does not involve evaluating text after 
the fact.  The data are mapped as soon as collected.   In other words, even if some elements of the 
medication data are omitted, we can always map to some level of the original source (RxNorm/UMLS).  
The key point is that the data are always interoperable, even when collected at varying levels of detail 
(or if some details are omitted). 
In the end, such a balance was deemed necessary to provide end users with the flexibility 
needed to capture medication history data across all possible clinical scenarios while still maintaining 
reasonable data integrity.  One takeaway is that capturing medication data in fully-specified RxNorm 
form 100% of the time may not be a realistic goal, but capturing components of RxNorm that can be 
used to reconstruct an approximation of RxNorm format is achievable.  As such, the system design was 
able to maximize data integrity without loss of flexibility. 
Evaluating speed and performance is difficult, in that it is very much context-specific, particularly 
when dealing with networked applications.  A more generalizable approach is to evaluate such a system 
based on principles of information theory and the branching factor of the search space [15,16].  In this 
case, the dynamic caching of data on the front end application reduced the number of round trips to the 
database from the application to a bounded upper limit of 2+(n-1), where n = number of medications to 
be entered.  As the search cache is stored, we are guaranteed to hit the database at least twice (once to 
create the search cache, and once more to update medication-specific caches), but for subsequent 
medications we only need a single round trip to the database.  Each round trip was estimated to average 
200 milliseconds, depending on the size of the search space of the query, maxing out at around 500 
milliseconds.  More importantly, the cache size is reduced, whereas there are a total of over 42,000 
different combinations of medication and common dosages in RxNorm.  Separating out the medications 
into a med_list table for the initial search cache reduces this to 18,694 distinct items.  The effective 
branching factor for common dose forms and dose units after initial medication search are 2.52 and 
1.18, respectively.  The represents a 55% reduction in overall cache size on average in the worst case 
scenario, or, assuming the caches are separated out but populated via queries, a 55% reduction in the 
search space to identify all medication components.  In other words, given that most medications only 
have 2-3 common dose forms and typically just one dose unit (e.g., mg), it us much more efficient to 
have separate lookup tables for those distinct from the main medication list itself.  This also enhances 
the efficiency of the keystroke-filtering auto-complete feature in the medication search box (see 
Methods).  In both cases, the information content is still the same.  Given Shannon’s equation [17]: 
 
     
 
Where b is typically 2.  We know the p(xi) to be 1/(total number of different combinations) for the 
general, non-reformatted case of RxNorm, and for the reformatted case the joint entropy p(xi) to be the 
multiplicative of 1/(search size), 1/(effective branching factor of common dose form, and 1/(effective 
branching factor of dose units).  Totaling H(x) for the various probabilities in each case gives us 
approximately ~15 bits in both cases (as expected theoretically). In other words, we reduce the needed 
cache size/search space and provide a bounded limit on the number of round trips to the database 
without loss of information.  In plain language, for such an application, restructuring RxNorm can convey 
the same information content more efficiently, which, obviously, has a positive impact on speed and 
performance regardless of system configuration. 
 The end product application was thus flexible, fast, and provided high-quality data capture in 
most respects.  The remaining issue was to evaluate was medication coverage.  As such, we compared 
the list of medications derived from RxNorm for this application to the existent legacy EHR medication 
data in Centerstone’s system over the course of 12 months (July 2010 – June 2011).  The legacy EHR 
medication data was populated via Infoscriber (http://ntst.com/products/infoscriber.asp), which 
captures standard medication names in a structured format.  A very simple matching algorithm that 
performed a straight match on medication name (i.e., where EHR Medication Name = RxNorm 
Medication Name, accounting for capitalization differences) was able to correctly cover 93.2% 
(85,795/92,058) of all prescriptions during that year-long time period.  Many of those non-matching 
medications were due to slight variations in naming (such as for “extended release versions of some 
medications, e.g., Venlafaxine vs. Venlafaxine ER, Seroquel vs. Seroquel XR) that could be easily correctly 
using a more complicated matching algorithm such as one based on regular expression pattern matching 
[4,12,18].  The other non-matching medications tended to be uncommonly prescribed medications 
and/or alternative therapy options such as nicotine cessation products, multivitamins, and dietary 
supplements (e.g., Omega-3 Fatty Acids).  These non-matching patterns are similar to findings reported 
elsewhere [19].  The overall coverage was thus judged to be adequate for the intended purpose in this 
case – capturing medication history that might impact current treatment decisions and/or the 
evaluation of current treatment effectiveness – given that 1) the coverage rates of prescription orders 
were in line with previously reported values [7,9,20] and, 2) the non-matching prescriptions were 
generally of a nature (e.g., spelling variations, vitamins) that would not interfere with that intended 
purpose. 
 
4. Discussion 
 As evidenced by the work presented here, RxNorm is a suitable terminology for capturing 
medication history in live EHRs.  A restructured dataset of RxNorm satisfies the necessary requirements.  
It provides fast and efficient data access for high I/O applications and Google-like auto-complete search 
functionality patterned off of the Medicare Part D Formulary Finder website 
(http://plancompare.medicare.gov/pfdn/FormularyFinder/).   It allows for flexibility to capture data in 
various, alternate clinical scenarios, such as when some data points are unknown or missing and 
RxNorm must be reconstructed from available component parts.  Even when providing such flexibility, 
the restructured RxNorm dataset allows capture of data with reasonable data integrity and quality.  A 
restructured RxNorm dataset can also provide excellent medication coverage, estimated at 93.2% in a 
large-scale, real-world outpatient behavioral healthcare setting.  Many of the prescriptions not covered 
were nicotine cessation products, multivitamins, and dietary supplements or due to slight spelling 
variations of medication name.  
 A number of other research efforts have obtained similar results in similar projects related to 
RxNorm, as well as other standardized terminologies such as SNOMED CT [4].  Fung et al. [5] extracted a 
subset of commonly prescribed medications into a tool called “RxTerms”.   Zeng et al. [8] developed a 
PHR-like tool called “MyMedicationList” that partially uses RxNorm for direct capture of medication 
history directly from patients, which was later extended to interact with provider/patient collaborate e-
prescribing tool called “MyRxPad” [21].  Nelson et al. [1] summarized many of these efforts.  Other 
researchers have focused efforts on utilizing RxNorm as part of specific research projects [2,19].  All of 
the aforementioned efforts have produced insights regarding application of RxNorm toward developing 
web-based tools, personal health records, and specific research studies.  This paper extends these 
studies by exploring the necessary steps toward implementation of RxNorm in an adapted form in EHRs.  
While many of the issues described elsewhere were similar to those presented here – e.g., coverage, 
flexibility, speed – some of the requirements for such an EHR application proved to be distinct, 
particularly in regards to I/O demands to support advanced caching and search functionality as well as  
flexible data capture across potential clinical scenarios.  Future applications of RxNorm in EHRs in other 
live clinical settings may further elucidate these issues.  
 There are multiple potential avenues for extension of this work, particularly in regard to search 
optimization and filtering as well as integrating drug classification schemes into RxNorm.   The search 
results could be improved via the use of web-search-like indexing and filtering, similar to commonly 
used information retrieval techniques utilizing click-throughs and page ranking [22].  Such algorithmic 
approaches to search optimization can also incorporate user profiling to personalize medication search 
results based on individual user behavior or behavior of users similar to the current individual [23].  In 
other words, the search results that a particular user (patient or provider) sees when entering 
medication information may be ranked or organized based on other medications they have entered 
during the current session or based on past user behavior.  For example, medications that are commonly 
prescribed in “clusters” for co-occurring disorders may be pushed to the top of the list if the patient is 
identified as fitting that profile or if one medicine from such a cluster is entered.  Additionally, search 
functionality could be enhanced through the use of “sounds like” technology, such as Metaphone, that 
allows users to phonetically spell medication names and find them via search even if they do not know 
the correct spelling [22].  On other fronts, efforts to classify RxNorm data into medication categories 
hold great promise for research, clinical decision support, and business intelligence purposes, whereas 
RxNorm currently lacks any such built-in categorization scheme..  Grouping medications into categories, 
such as by linking to NDF-RT, enables cross-organizational, cross-population, cross-provider, and cross-
diagnostic comparisons, among other capabilities.  However, there is still progress to be made in this 
arena, particularly in achieving better coverage/linkage of medications between RxNorm and drug 
categorization schemes [7,19].  
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